about
Comparison of speech and language therapy techniques for speech problems in Parkinson's diseaseSpeech and language therapy versus placebo or no intervention for speech problems in Parkinson's diseaseChanges in Rat 50-kHz Ultrasonic Vocalizations During Dopamine Denervation and Aging: Relevance to NeurodegenerationEvidence for early and progressive ultrasonic vocalization and oromotor deficits in a PINK1 gene knockout rat model of Parkinson's diseaseRelationships among rat ultrasonic vocalizations, behavioral measures of striatal dopamine loss, and striatal tyrosine hydroxylase immunoreactivity at acute and chronic time points following unilateral 6-hydroxydopamine-induced dopamine depletion.Decreased approach behavior and nucleus accumbens immediate early gene expression in response to Parkinsonian ultrasonic vocalizations in rats.Atp13a2 expression in the periaqueductal gray is decreased in the Pink1 -/- rat model of Parkinson disease.Early identification and treatment of communication and swallowing deficits in Parkinson disease.Vocalization deficits in mice over-expressing alpha-synuclein, a model of pre-manifest Parkinson's disease.Dopamine D1 and D2 receptor antagonism effects on rat ultrasonic vocalizations.Qualitative changes in ultrasonic vocalization in rats after unilateral dopamine depletion or haloperidol: a preliminary study.Re-emergence of childhood stuttering in Parkinson's disease: a hypothesis.Speech and language therapy for dysarthria in Parkinson's disease.A comparison of speech and language therapy techniques for dysarthria in Parkinson's disease.Characterization of early-onset motor deficits in the Pink1-/- mouse model of Parkinson disease.Assessment of voice and speech symptoms in early Parkinson's disease by the Robertson dysarthria profile.Characterization of oromotor and limb motor dysfunction in the DJ1 -/- model of Parkinson disease.Effects of dopaminergic replacement therapy on motor speech disorders in Parkinson's disease: longitudinal follow-up study on previously untreated patients.Residual signal auto-correlation to evaluate speech in Parkinson's disease patients.Quantitative Analysis of Catecholamines in the Pink1 -/- Rat Model of Early-onset Parkinson's Disease.A data mining methodology for predicting early stage Parkinson's disease using non-invasive, high-dimensional gait sensor data.
P2860
Q24201335-452C3B71-8FF5-4E5E-801E-D87057A991F5Q24201565-70007AF5-C466-49C4-87EF-761E656C760BQ26786494-B201C984-91D4-4A06-AE28-4144BEF05D9CQ30371129-AED5357E-C934-451D-B1F1-A40F0F9A618EQ30374427-AEA0C8CC-E75C-42AF-A2D0-859A1ECEFA0EQ30377972-94D76D32-AC01-40CB-BC6C-BC7C2A5B2799Q30383670-1A139571-42E3-4FC7-BE91-190F9D9F1890Q30408790-C8422511-3D72-4ED8-898C-F126F047B702Q30415147-999F9E04-7BE8-47B2-B51A-89190D9E66C0Q30431683-8C13074B-D5B1-40F1-824B-D88E16F1C066Q30493550-1ED44B50-7963-4E52-AA1E-607D1741B9C0Q34160166-3F5412D3-13D6-45A8-8BBA-45D011B88522Q34281931-993211E1-35A6-4F04-8705-A8A89B3AA001Q34281936-8B06DE52-212F-4DA2-A21B-A0D62B694109Q47327885-71294A16-3A4E-404B-99E9-C36D9E76F08DQ47897706-50F9E7CE-AF1E-474A-BB65-F2B716EBD209Q47983420-EE731B52-C6F7-446F-B043-8477E5547A93Q50243326-0591AC46-A984-4E6B-91DC-39AB85C54D5FQ51084282-A735D9A2-8B14-4EAB-B131-8AB4C01850EFQ52370317-95FFE21C-0E96-4A9D-9180-C6400A6B6A3DQ53242756-87C65A62-C9EC-49A7-A938-9236FBD9733F
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Speech dysfunction in early Parkinson's disease.
@en
Speech dysfunction in early Parkinson's disease.
@nl
type
label
Speech dysfunction in early Parkinson's disease.
@en
Speech dysfunction in early Parkinson's disease.
@nl
prefLabel
Speech dysfunction in early Parkinson's disease.
@en
Speech dysfunction in early Parkinson's disease.
@nl
P2093
P2860
P356
P1433
P1476
Speech dysfunction in early Parkinson's disease.
@en
P2093
P2860
P304
P356
10.1002/MDS.870100506
P407
P50
P577
1995-09-01T00:00:00Z